Methanesulfonic acid methyl 2-imino-3-methyl-2,3-dihydro-1,3-benzothiazole-6-carboxylate
CAS: 2034455-56-4
Ref. 3D-JGD45556
| 1g | Ausgelaufen | ||
| 50mg | Ausgelaufen | ||
| 100mg | Ausgelaufen | ||
| 250mg | Ausgelaufen | ||
| 500mg | Ausgelaufen |
Produktinformation
Name:
Methanesulfonic acid methyl 2-imino-3-methyl-2,3-dihydro-1,3-benzothiazole-6-carboxylate
Beschreibung:
Methanesulfonic acid methyl 2-imino-3-methyl-2,3-dihydro-1,3-benzothiazole-6-carboxylate (MSI) is a derivative of imatinib and has been used in the treatment of cancer. MSI is a reactive compound that can form hydrogen bonds with other compounds. It has been shown to have an acidic pH of 1.0 in water vapor. MSI also has an absorption maximum at 280 nm due to the presence of a trifluoromethanesulfonic acid group. MSI crystallizes into different polymorphs depending on the conditions under which it is purified, including amorphous and crystalline solids. The particle size distribution for these polymorphs ranges from 0.1 to 5 microns, with an average particle size of 1 micron.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
318.4 g/mol
Formel:
C11H14N2O5S2
Reinheit:
Min. 95%
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
